Annaly Capital Management Operating Cash Flow decreased by 317.5% to -$1.40B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 796.8%, from -$156.27M to -$1.40B. Over 3 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -39.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $506.49M | $644.24M | $861.56M | $2.03B | $687.70M | $2.45B | $201.58M | -$1.02B | $1.14B | $1.87B | $378.52M | $1.70B | $477.07M | $2.81B | -$156.27M | $180.74M | $24.09M | $644.34M | -$1.40B |
| QoQ Change | — | +27.2% | +33.7% | +135.5% | -66.1% | +256.8% | -91.8% | -605.5% | +211.5% | +64.6% | -79.8% | +348.6% | -71.9% | +488.7% | -105.6% | +215.7% | -86.7% | >999% | -317.5% |
| YoY Change | — | — | — | — | +35.8% | +280.9% | -76.6% | -150.2% | +65.3% | -23.8% | +87.8% | +266.6% | -58.0% | +642.0% | -109.2% | -62.1% | — | -77.1% | -796.8% |